Evidence map›Paper›PMID 22808270›Full record

ArticlePloS one2012

A reverse time-course method for transcriptional chase analyses of mRNA half-lives in cultured cells.

Osheiza Abdulmalik, Alyssa A Lombardi, J Eric Russell

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Structural determinants of human ζ-globin mRNA stability.Journal of hematology & oncology · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Osheiza AbdulmalikDepartment of Pediatrics Hematology, University of Pennsylvania School of Medicine and The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America. abdulmalik@email.chop.edu
Alyssa A Lombardi
J Eric Russell
Children's Hospital of Philadelphia · US

Funding

REGULATION AND FUNCTION OF A HUMAN EMBRYONIC GLOBINR01HL061399 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI RUSSELL, J ERIC · 1999 to 2012
$3.9M
Nucleolin-mediated stabilization of human B-globin mRNAR01HL082754 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI RUSSELL, J ERIC · 2007 to 2011
$2.0M
Structure and Function of Stability-Enhanced Beta-Globin mRNAsK01HL103186 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI ABDULMALIK, OSHEIZA Y · 2010 to 2014
$697k
NHLBI NIH HHS K01 HL103186NHLBI NIH HHS K01-HL103186NHLBI NIH HHS R01 HL061399NHLBI NIH HHS R01-HL061399NHLBI NIH HHS R01 HL082754NHLBI NIH HHS R01-HL082754
6 · The paper itself

Abstract

Standard methods for assessing mRNA stabilities in intact cells are labor-intensive and can generate half-life (t(1/2)) measures that are both imprecise and inaccurate. We describe modifications to a conventional tetracycline-conditional transcriptional chase method for analyzing mRNA stability that significantly simplify its conduct, while generating highly reproducible and accurate t(1/2) values. The revised method-which is conducted as a reverse time course, and which accounts for interval expansion in the number of cultured cells-is validated for the analyses of mRNAs with both short and long half-lives. This approach facilitates accurate assessment of mRNA metabolism, providing a user-friendly tool for detailed investigations into their structures and functions, as well as the processes that contribute to their post-transcriptional regulation.

Indexed as

Genetic TechniquesTranscription, GeneticCell ProliferationDoxycyclineHalf-LifeHeLa CellsHumansRNA, MessengerRNA StabilityTime FactorsDoxycyclineRNA, Messenger

Identifiers

PMID22808270
PMCPMC3396636
OpenAlexW2090366233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.